Clariane SE (LON:0OPS)
London
· Delayed Price · Currency is GBP · Price in EUR 5.20
-0.05 (-0.93%)
At close: Jul 8, 2025
Clariane SE Revenue
In the year 2024, Clariane SE had annual revenue of 5.28B EUR with 5.73% growth. Clariane SE had revenue of 2.65B in the half year ending December 31, 2024, with 16.31% growth.
Revenue
5.28B EUR
Revenue Growth
+5.73%
P/S Ratio
0.38
Revenue / Employee
85.47K EUR
Employees
61,798
Market Cap
1.64B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.28B | 286.17M | 5.73% |
| Dec 31, 2023 | 5.00B | 557.29M | 12.56% |
| Dec 31, 2022 | 4.44B | 300.99M | 7.27% |
| Dec 31, 2021 | 4.14B | 364.40M | 9.66% |
| Dec 31, 2020 | 3.77B | 160.41M | 4.44% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |